Angiogenetic tissue in a number of tumors, like breast cancer, prostate cancer, kidney cancer, liver cancer, and other tumors, overexpresses prostate-specific membrane antigen (PSMA) [7,16]. Here, FOLH1 is linked to prostate carcinoma.